Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med., 13 January 2022
Sec. Cardiovascular Biologics and Regenerative Medicine
This article is part of the Research Topic Strategies to Improve Cardiac Function: Novel ideas and future concepts View all 8 articles

RETRACTED: STK35 Gene Therapy Attenuates Endothelial Dysfunction and Improves Cardiac Function in Diabetes

Retracted
  • 1Department of Molecular Pharmacology & Physiology, Morsani College of Medicine, Bryd Alzheimer's Research Institute, University of South Florida, Tampa, FL, United States
  • 2Center for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States
  • 3Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, United States
  • 4Department of Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL, United States
  • 5Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, AL, United States

Citation: Joladarashi D, Zhu Y, Willman M, Nash K, Cimini M, Thandavarayan RA, Youker KA, Song X, Ren D, Li J, Kishore R, Krishnamurthy P and Wang L (2022) STK35 Gene Therapy Attenuates Endothelial Dysfunction and Improves Cardiac Function in Diabetes. Front. Cardiovasc. Med. 8:798091. doi: 10.3389/fcvm.2021.798091

Received: 19 October 2021; Accepted: 22 December 2021;
Published: 13 January 2022; Retracted: 09 May 2023.

Edited by:

Nicolle Kraenkel, Charité University Medicine Berlin, Germany

Reviewed by:

Zhao Wang, City of Hope National Medical Center, United States
Amaresh Ranjan, Midwestern University, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.